Roche expanding capacity 40% across network, but will still use CMOs
Roche is expanding its manufacturing operations to service its biologics pipeline, but the firm says it will continue to outsource approximately 20% of all production.
Archives for July 23, 2015
BioFinance Vision: Are Pfizer and Novartis in the biosimilar saddle?
With Pfizer closing in on Hospira and Sandoz set to launch Zarxio in the US, it’s been a defining week for biosimilars, our BioFinance Vision feature explains.
Stem cell factories: New substrate opens door to mass produced regenerative therapies
Mass produced regenerative therapies are a step closer say UK researchers who have developed a polymer substrate they claim can be used to set up “stem cell factories.”